STING1 and HIV infectious disease: Future studies should delineate how HIV utilizes the IFI16/cGAS-STING signaling and other factors involved in immune impairment and explore whether modulating the pathway can serve as a viable strategy to counteract immune suppression in HIV infection, both in untreated and ART treated individuals.